Systematic review of 6 observational studies (n=1,161; 4 meta-analysed for clinical cure) in MDR/DTR P. aeruginosa: ceftolozane-tazobactam was associated with higher clinical cure than ceftazidime-avibactam (OR 1.82); no difference in 30-day mortality or resistance.
Meta-analysisn = 1,161
Gatti et al. Comparison of Ceftolozane-Tazobactam and Ceftazidime-Avibactam in the Treatment of Multidrug-Resistant/Difficult-to-Treat Resistant Pseudomonas aeruginosa Infections: A Systematic Review and Meta-analysis